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Abstract
Youth are particularly vulnerable to acquiring HIV, yet reaching them with HIV prevention 
interventions and engaging and retaining those infected in care and treatment remains a challenge. 
We sought to determine the incidence rate of loss to follow-up (LTFU) and explore socio-
demographic and clinical characteristics associated with LTFU among HIV-positive youth aged 
15–21 years accessing outpatient care and treatment clinics in Kisumu, Kenya. Between July 2007 
and September 2010, youth were enrolled into two different HIV care and treatment clinics, one 
youth specific and the other family oriented. An individual was defined as LTFU when absent 
from the HIV treatment clinic for ≥ 4 months regardless of their antiretroviral treatment status. 
The incidence rate of LTFU was calculated and Cox regression analysis used to identify factors 
associated with LTFU. A total of 924 youth (79% female) were enrolled, with a median age of 20 
years (IQR 18-21). Over half, (529 (57%)), were documented as LTFU, of whom 139 (26%) were 
LTFU immediately after enrolment. The overall incidence rate of LTFU was 52.9 per 100 person-
years (p-y). Factors associated with LTFU were pregnancy during the study period (crude HR 
0.68, 95% CI 0.53–0.89); CD4 cell count ≥350 (adjusted hazard ratios (AHR) 0.59, 95% CI 0.39–
0.90); not being on antiretroviral therapy (AHR 4.0, 95% CI 2.70–5.88); and nondisclosure of HIV 
infection status (AHR 1.43, 95% CI 1.10–1.89). The clinic of enrolment, age, marital status, 
employment status, WHO clinical disease stage and education level were not associated with 
LTFU. Interventions to identify and enrol youth into care earlier, support disclosure, and initiate 
ART earlier may improve retention of youth and need further investigation. Further research is 
also needed to explore the reasons for LTFU from care among HIV-infected youth and the true 
outcomes of these patients.
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Adolescents and youth aged 15–24 years are among the populations most impacted by the 
global HIV epidemic, with an estimated 40% of all daily 6300 new infections occurring in 
this age group (Auld et al., 2014). Approximately two-thirds of the world's more than 10 
million HIV-infected young people aged 15–24 years live in sub-Saharan Africa, accounting 
for 20% of all people living with HIV in this region (Lamb et al., 2014). HIV represents a 
continuing threat to the youth in Kenya, who comprise 38% of the national population but 
are believed to make up more than 60% of new HIV infections (Harper et al., 2014; National 
AIDS and STI Control Programme (NASCOP) & National AIDS Control Council, 2012; 
Nöstlinger et al., 2015).With such a large and growing burden of the disease among youth, 
and the life-long nature of HIV treatment, strategies that focus on their enrolment and 
retention into HIV care are paramount (Lamb et al., 2014).
Retention in care and adherence to antiretroviral therapy (ART) are critical for the optimal 
success of HIV treatment scale-up (Gwynn et al., 2015; Tweya et al., 2013). Adolescents 
and young adults living with HIV have complex medical and psychological needs and many 
disengage from health services (Hughes et al., 2013; Wolf et al., 2014). Due to factors such 
as poverty, marginalization, stigma, lack of social support structures and low self-perception 
of risk, youth may engage in high-risk health behaviour (e.g., defaulting from care) despite 
knowing the possible adverse consequences; they simply do not rationally weigh the relative 
risks and consequences of their actions (Shroufi et al., 2013).
There is paucity of data on the outcomes of youth enrolled in HIV care in sub-Saharan 
Africa (Lamb et al., 2014). We sought to determine the incidence rate of loss to follow-up 
(LTFU) and to explore socio-demographic factors and clinical characteristics associated with 
LTFU among HIV-infected youth accessing outpatient HIV care and treatment services in 
select facilities in Kisumu, Kenya.
Methods
Study design
This retrospective cohort analysis used data routinely collected from HIV-infected patients 
enrolled in care at Lumumba Health Centre and at Tuungane Youth Centre, both in Kisumu, 
Kenya. Patients aged 15–21 years who enrolled into care between July 2007 and September 
2010 were included in the analysis. The protocol was reviewed and approved by the Kenya 
Medical Research Institute (KEMRI) ethical review committee and the University of 
California San Francisco (UCSF) Committee on Human Research prior to the abstraction of 
de-identified and delinked data from the medical records.
Programme description
Family AIDS Care & Education Services (FACES) is a family-centred HIV prevention, care 
and treatment programme funded by the US President's Emergency Plan for AIDS Relief 
(PEPFAR) through a cooperative agreement with the Centres for Disease Control and 
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Prevention (CDC). It is a collaborative effort between KEMRI and UCSF. The FACES 
family model of care has been described elsewhere (Lewis Kulzer et al., 2012).
Tuungane Youth Centre is a youth-oriented HIV prevention, care and treatment clinic run by 
the Impact Research and Development Organization (IRDO) and is funded by PEPFAR 
through a cooperative agreement with the CDC.
In November 2005, FACES and IRDO began a collaboration to expand the HIV services for 
youth at Tuungane Youth Centre by adding HIV care and treatment to the prevention 
services already existing at the centre. In this way, young people could access a full 
spectrum of youth-focused HIV prevention, care and treatment services in a youth-friendly 
environment.
Care at both Lumumba Health Centre and Tuungane Youth Centre is offered with no fees 
charged. To facilitate high quality of care, patient encounters are recorded on standardized 
clinical forms, and staff members from FACES and IRDO hold joint weekly continuous 
medical education sessions and rotate staff between the two clinics.
At both sites, patients meeting the following criteria were initiated on ART, in accordance 
with the Kenyan national HIV treatment guidelines: WHO Stage I & II with a CD4 cell 
count of < 350 cells/mm3; WHO Stage III & IV regardless of CD4 cell count; TB/HIV co-
infection; and TB/HIB co-infection with evidence of liver disease (NASCOP, 2011).
By September 2010, Lumumba Health Centre had 10,010 patients active in care, of whom 
338 (3.4%) were aged 15–21 years, and Tuungane Youth Centre had 1424 HIV-positive 
patients active in care, of whom 431 (30.4%) were within that age range.
Missed appointments and defaulter tracing
To improve patient retention, FACES, through its Clinic and Community Health Assistants 
(CCHAs), runs an active defaulter tracing program. Upon enrolment, each patient's address 
and contact information are recorded. A patient missing his/her appointment is identified 
from the clinic daily attendance register and is actively sought three days after a missed 
appointment through the use of phone calls and/or a home visit. A similar cadre of staff in 
the outreach department at Tuungane Youth Centre implements a similar defaulter tracing 
mechanism. Due to staff and transportation constraints, the vast geographical coverage area, 
and inconsistent and sometime unreliable patient locator information, not all patients can be 
traced. Defaulter tracing is prioritized for patients who have recently initiated ART, 
expectant mothers and children.
Data collection
In April 2007, an open-source electronic medical records system (OpenMRS) was launched 
at Lumumba Health Centre and was extended to Tuungane Youth Centre in July 2007. 
Socio-demographic, clinical, laboratory and pharmacological data collected at each patient 
visit was recorded on standardized clinical visit forms then manually entered into OpenMRS 
on a daily basis.
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The primary outcome for this analysis was LTFU, defined as a patient missing his/her last 
appointment by ≥ 4 months. The baseline socio-demographic and clinical characteristics 
examined for association with LTFU included: age, marital/civil status, clinic type, WHO 
clinical disease stage, disclosure of HIV-infection status, becoming pregnant during the 
study and highest education level. We also examined ART status at the time of LTFU for 
association with LTFU. Patients known to have transferred to a different care location, were 
deceased, or withdrew from care were not considered as LTFU.
Data analysis
The two-sample t-test was used to compare continuous variables and the Chi-square (χ2) 
test was used to compare categorical variables between patients enrolled at the youth-
specific clinic and those at the family-oriented clinic during the study period. The incidence 
rate of LTFU is presented as events per 100 person-years (p-y), from date of enrolment. The 
event date of LTFU was defined as the date of the last clinic visit in the medical records. For 
patients determined to have been transferred out, withdrawn or deceased, data were censored 
at their date of last appointment or date of death. Data on patients still in active care at the 
end of the study period were censored at the date of their last clinic visit. The log-rank test 
was used to compare survival curves for LTFU. Cox regression was used to identify factors 
independently associated with LTFU and to estimate crude and adjusted hazard ratios 
(AHRs) for LTFU. AHRs and associated 95% confidence intervals (CI) were calculated 
from a single model that included all patient demographic and clinical characteristics under 
examination. All analyses were performed using STATA version 11/SE software (StataCorp 
LP, College Station, TX, USA).
Results
Patient characteristics
Between 23 July 2007 and 26 September 2010, 924 patients were identified as eligible for 
inclusion in the data analysis: 584 (63%) at the youth-specific clinic and 340 (37%) at the 
family-oriented clinic. Patients had a median age of 20 years (IQR 18–21), 732 (79%) were 
female and only 55 (6%) were reported as having some form of employment. Two hundred 
and nine women were reported as having become pregnant during the study (Table 1).
Patient characteristics by clinic type
Patients at the family-oriented clinic were younger (p < .001), more likely to be female (p < .
001), married (p < .001), working/employed (p < .001), more likely to have become 
pregnant during the study (p < .001) and more likely to have disclosed their HIV status (p = .
001). Patients at the youth-specific site had higher median CD4 cell counts (p = .001), had 
higher education level (p = .001) and were less likely to have ever initiated ART (p < .001) 
(Table 2).
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Of 924 eligible patients, 529 (57%) were LTFU by close of study, 418 (79%) of whom were 
female. Of patients who were LTFU, 354 (67%) were from the youth-specific clinic. Only 
60 patients (7%) were identified as discontinued from care (9 deceased, 48 transferred to 
other clinics and 3 withdrew from care) and were thus not defined as LTFU.
Patients contributed a total of 734 p-y of follow-up, with a mean individual contribution of 
0.9 years. Of 529 patients who were LTFU, 139 (26%) were lost immediately after 
enrolment, and the median time to LTFU was 1.4 years (95% CI 1.1–1.6). Overall the 
incidence rate for LTFU was 52.9(95% CI 47.9–58.4) patients per 100 p-y. The incidence 
rate for LTFU was significantly greater among patients who never started ART compared to 
those who had ever initiated ART (Log rank p < .001) (Figure 1), and among those who had 
not disclosed their status compared to those who had (Log-rank test, p = .001) (Figure 2).
In the univariate Cox regression analysis, compared to female patients who did not become 
pregnant at any time during the study period, those who did had 32% lower hazards of being 
LTFU (crude HR 0.68, 95% CI 0.53–0.89). Male patients were no more likely to become 
LTFU when compared to non-pregnant females (crude HR 0.97, 95% CI 0.54–1.24). 
Patients who had never initiated on ART at the time of being LTFU had a 52% higher hazard 
of being LTFU compared to those who had ever started ART (crude HR 1.52, 95% CI 1.22–
1.89). Clinic of enrolment, age, marital status, occupational status, WHO HIV clinical 
disease stage, education level and disclosure status were not associated with LTFU in the 
univariate analysis (Table 3).
In the multivariable Cox regression analysis, compared to patients who had CD4 cell counts 
<250 cells/mm3, patients who had CD4 cell counts ≥ 350 cells/mm3 had a 41% lower hazard 
of being LTFU (AHR 0.59, 95% CI 0.39–0.90). Patients who had never started ART had 
four times higher hazards of becoming LTFU compared to those who had ever initiated ART 
(AHR 4.0, 95% CI 2.70–5.88). Compared to those who had disclosed their status to anyone 
(family/friends), those who had never disclosed had a 43% higher hazard of becoming LTFU 
(AHR 1.43, 95% CI 1.10–1.89). Pregnancy had no significant association with LTFU in the 
multivariable analysis, suggesting confounding. Type of clinic, age, marital status, 
employment status, WHO HIV clinical disease stage and education level were not associated 
with LTFU in the multivariable analysis (Table 3).
Discussion
LTFU was very high in this vulnerable population in both the youth-specific and family-
oriented clinics, with more than half of the patients enrolled into care being documented as 
LTFU. The LTFU incidence of 52.9 per 100 p-y among this population is up to twice that 
seen among adults in HIV care and treatment programmes, whose LTFU rates range from 
9% to 26%, with an annual incidence rate of 14–27 per 100 p-y (Charurat et al., 2010; 
Ochieng-Ooko et al., 2010).While some studies have shown that HIV-infected youth in 
adult-oriented clinics are less likely to start treatment, achieve viral suppression and stay on 
treatment compared to adults (Auld et al., 2014; Evans et al., 2013; Lamb et al., 2014); 
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others have observed rates of LTFU twice as high in adults than in adolescents (Shroufi et 
al., 2013).
Identifying modifiable clinic-level factors associated with patient retention may suggest 
feasible points of intervention (Lamb, El-Sadr, Geng, & Nash, 2012). In our study, patients 
who had never been on ART had a higher LTFU rate, a finding consistent with studies done 
elsewhere among adult populations (Clouse et al., 2013). In a setting where patients often 
present for care in advanced stages of disease, this may mean that sicker patients, on ART, 
are more likely to remain in care since they are on treatment. On the other hand, it also 
suggests that less immunocompromised, healthier patients are less likely to remain in care 
(Gwynn et al., 2015). The association between ART and LTFU could also be a result of 
survivor bias, since only patients who remain in care long enough can be initiated on ART. 
We did not assess the time to ART initiation and its association with LTFU in this study.
In our study, patients who had CD4 cell counts ≥ 350 cell/mm3were less likely to become 
LTFU. This could be suggestive of patients with lower CD4 cell counts being too sick to 
continue on care, transferring to clinics closer to them, or they may have died, unbeknown to 
their care providers (Tweya et al., 2013).
We also demonstrate that patients who had never disclosed their serostatus to anyone were 
more likely to become LTFU. Disclosure of HIV status has been shown to be associated 
with higher retention in care (Arrivé et al., 2012). Disclosure might have benefits for HIV-
infected adolescents and youth, such as improved adherence to ART, and engagement of 
social support (Arrivé et al., 2012; Hill, Maman, Groves, & Moodley, 2015; Wolf et al., 
2014). Therefore, screening of HIV-infected youth for social support needs and 
identification of sources for social support should be regularized as part of care. Material on 
disclosure should be readily availed for adaptation, evaluation and broader implementation 
in resource-limited settings (Vreeman, Gramelspacher, Gisore, Scanlon, & Nyandiko, 2013).
Though a majority of patients in this study were female, there was no association between 
gender and LTFU. Amir et al also observed a similar finding among adolescents (Shroufi et 
al., 2013). While others have found adult men to be at higher risk of LTFU, (Ahmed, Gugsa, 
Lemma, & Demissie, 2013; Mugisha et al., 2014), Gwynn et al observed a higher retention 
rate among men compared to women in a family-focused model of care. They also show 
pregnant women to be at higher risk of being LTFU compared to non-pregnant women 
(Gwynn et al., 2015). After controlling for other factors, we did not detect statistical 
association of pregnancy with LTFU, similar to findings from rural Nigeria (Aliyu et al., 
2015).
A growing number of adolescents are now entering care in adult-oriented HIV clinics and 
criteria should be put in place to assist them or to guide clinic staff in how best to treat this 
vulnerable patient category within these settings. The adult-oriented HIV care model may 
not meet the specific needs of the youth as they face unique challenges in the management 
of HIV (Evans et al., 2013).Though family support may seem to be more important for HIV-
infected youth than a youth-friendly environment in and of itself, adolescent-friendly 
services may improve access and retention in care (Shroufi et al., 2013). Further exploration 
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of the reasons youth sought care at either clinic could help to ensure that services meet the 
expectations of HIV-infected youth with varied backgrounds and needs.
Implications of findings
The high LTFU immediately after enrolment calls for targeted interventions (Evans et al., 
2013) and intensified patient education on the importance of adherence to clinic 
appointments during the first encounter. The availability of educational materials and 
adherence counselling services in ART clinics have been associated with lower rates of 
LTFU (Bygrave et al., 2012; Lamb et al., 2012).
The finding that never initiating ART was associated with higher chances of being LTFU 
call for strategies that enable earlier initiation of ART and promote retention in care (Clouse 
et al., 2013). The 2013 WHO HIV treatment guidelines, recently adopted in Kenya (Ministry 
of Health; National AIDS and STI Control Program, 2014), strongly recommend that ART 
be initiated in all HIV-infected adolescents and adults with CD4 count ≤ 500 cells/mm3, 
regardless of WHO clinical stage (WHO, 2013). There is also need for aggressive tracing of 
HIV-infected youth LTFU but are not yet on ART, since this population is more likely to 
have worse outcomes when they do eventually return to care (Lamb et al., 2014).
Study strengths and weaknesses
The follow-up period of three years and a sizeable population were relative strengths of this 
study, although the findings cannot be generalizable to the entire 15–21-year-old HIV-
positive population of Kenya because it involved only two clinics in Kisumu. We did not 
ascertain the true outcomes of the patients who were documented as being LTFU. Studies 
tracing patients LTFU found high unascertained deaths and transfers, suggesting both 
contribute substantially to LTFU (Lamb et al., 2012; Tweya et al., 2013). Thorough tracing 
of a random sample of patients documented as LTFU would help determine site-specific 
reasons for and outcomes among these patients (Geng et al., 2010).
We neither ascertained the age at disclosure nor the strategies implemented in conducting 
the disclosure since this was a retrospective chart review. We also reported disclosure status 
as a dichotomous variable only at enrolment, yet it is a process that evolves over time 
(Arrivé et al., 2012; Siu, Bakeera-Kitaka, Kennedy, Dhabangi, & Kambugu, 2012).
Finally, though distance has been recognized as a barrier to accessing healthcare 
(Moneyham et al., 2010; Tweya et al., 2013) among HIV-infected patients, we did not have 
data to explore distance as a factor in becoming LTFU. In Kenya, since 2006, HIV services 
have largely been decentralized from secondary health facilities to an expanded network 
including primary health facilities. This strategy of expanding HIV services has been shown 
to be associated with reduced rates of pre-ART LTFU (Reidy et al., 2014).
Conclusion
LTFU was very high among HIV-infected youth enrolled in HIV care and treatment services 
at these two clinics. Innovative approaches to retain them, even at youth-specific clinics, are 
urgently required. Ongoing evaluation of LTFU among HIV-positive youth is required and 
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care needs to be taken to disaggregate their numbers from the general LTFU data reported by 
most programmes. Interventions to identify and enrol youth into care earlier, support 
disclosure and initiate ART earlier may improve retention of youth and need further 
investigation. Further research is also needed to explore the reasons for LTFU from care 
among HIV-infected youth and the true outcomes of these patients.
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Kaplan–Meier survival curves for being lost to follow-up, by ART status, among youth 
accessing outpatient HIV care and treatment services in Kisumu, Kenya, July 2007–
September 2010.
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Kaplan–Meier survival curves for being lost to follow-up, by HIV infection disclosure 
status, among youth accessing outpatient HIV care and treatment services in Kisumu, 
Kenya, July 2007–September 2010.
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Table 1
Characteristics of youth accessing outpatient HIV care and treatment services in Kisumu, Kenya, from July 
2007– September 2010.
Characteristic Number (%)
Total number enrolled 924
 Youth-specific clinic 584 (63)
 Family-oriented clinic 340 (37)
Median age (years) 20 (IQR: 18–21)
Gender (female) 732 (79)
Became pregnant during study follow up 209 (29)
Marital status
 Married/partnered 295 (32)
 Not married/partnered 471 (51)
 Status not recorded 158 (17)
Currently working/employed 55 (6)
Median CD4 count (cells/mm3) 411 (IQR: 232–607)
CD4 cell count (cells/mm3)
 <250 219 (24)
 250–349 96 (10)
 ≥350 480 (52)
 CD4 cell count not documented 129 (14)
WHO Clinical staging and disease classification
 Stage I/II 737 (80)
 Stage III/IV 172 (19)
 Staging not recorded 15 (2)
Highest education level attained
 None 14 (1)
 Primary 532 (58)
 Secondary 250 (27)
 Tertiary 38 (4)
 Not recorded 90 (10)
Disclosed HIV infection status
 Yes 591 (64)
 No 268 (29)
 Disclosure status not documented 65 (7)
Ever initiated on ART 364 (39)
Number discontinued from care 60 (7)
 Deceased 9 (1)
 Transferred to another clinic 48 (5)
 Withdrew from care 3 (0.3)
Total number lost to follow-up 527 (57)
 Youth-specific clinic 351 (60)
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Characteristic Number (%)
 Family-oriented clinic 176 (51)
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Table 2
Characteristics of youth accessing outpatient HIV care and treatment services in Kisumu, Kenya, by clinic 
type, July 2007–September 2010.
Characteristic Total (n = 924) Youth-specific clinic (n = 584) Family-oriented clinic (n = 340) p-value
Median age (years) 20 (IQR 19–21) 19 (IQR 18–20) <0.001
Gender (female) 732 (79%) 418 (72%) 314 (92%) <0.001
Became pregnant during study 209 (23%) 64 (11%) 145 (43%) <0.001
Marital statusa
 Married/partnered 295 (32%) 129 (22%) 166 (49%) <0.001
 Not married/partnered 471 (51%) 363 (62%) 108 (32%)
Currently working/employed 55 (6%) 13 (2%) 42 (12%) <0.001
Median CD4 count (cells/mm3) 446 (IQR 275–675) 401 (IQR 217–576) 0.001
CD4 cell count (cells/mm3)b
 <250 219 (24%) 159 (27%) 60 (18%) 0.014
 250–349 96 (10%) 56 (9%) 40 (12%)
 ≥350 480 (52%) 300 (52%) 179 (52%)
WHO clinical disease stagec
 Stage I/II 737 (80%) 474 (81%) 263 (77%) 0.098
 Stage III/IV 172 (19%) 99 (17%) 73 (21%)
Highest education level attainedd
 None 14 (2%) 10 (2%) 4 (1%) 0.002
 Primary 532 (58%) 309 (53%) 223 (65%)
 Secondary 250 (27%) 167 (29%) 83 (24%)
 Tertiary 38 (4%) 32 (5%) 6 (2%)
Disclosed HIV infection status 591 (64%) 346 (59%) 245 (75%) 0.001
Ever initiated on ART 364 (39%) 204 (35%) 160 (47%) <0.001
Discontinued from care 60 (7%) 25 (4%) 35 (10%)
 Deceased 9 (1%) 5 (1%) 4 (1%) 0.27
 Transferred out 48 (5%) 20 (3%) 28 (8%)
 Withdrew from care 3 (0.3%) 0 3 (1%)
Lost to follow-up 529 (57%) 354 (61%) 175 (51%) 0.007
a
Marital status was missing for 158 patients (17%).
b
CD4 cell count was missing for 129 patients (14%).
c
WHO staging was missing for 15 patients (2%).
d
Educational status was missing for 90 patients (10%).
e
Disclosure status was missing for 65 patients (7%).
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